These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 373098)
21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
22. [Therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and stem cell transplantation]. Schmitz N Praxis (Bern 1994); 1998 Jun; 87(25-26):863-8. PubMed ID: 9702088 [TBL] [Abstract][Full Text] [Related]
23. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement. Bird JM; Luger S; Mangan P; Edelstein M; Silberstein L; Powlis W; Ball J; Schultz DJ; Stadtmauer EA Bone Marrow Transplant; 1996 Aug; 18(2):309-13. PubMed ID: 8864439 [TBL] [Abstract][Full Text] [Related]
24. Treatment of malignant lymphomas with very-high-dose CVB followed by transplantation of autologous blood stem cells collected after mobilizing chemotherapy. Majolino I; Scimè R; Indovina A; Vasta S; Patti C; Gentile S; Santoro A; Di Noto R; Fabbiano F; Guarnaccia C Haematologica; 1991 Mar; 76 Suppl 1():66-71. PubMed ID: 1713875 [TBL] [Abstract][Full Text] [Related]
25. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of neoplastic hematologic diseases with intensive radio-chemotherapy and transplantation of cryopreserved autologous bone marrow]. Nemet D; Labar B; Bogdanić V; Kolevska T; Mrsić M; Pavletić Z; Kalenić S; Vrtar M; Marusić M; Markulin-Grgić L Lijec Vjesn; 1989; 111(9-10):348-53. PubMed ID: 2633014 [TBL] [Abstract][Full Text] [Related]
27. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A Bone Marrow Transplant; 1990 Nov; 6(5):291-4. PubMed ID: 2291991 [TBL] [Abstract][Full Text] [Related]
28. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Appelbaum FR; Herzig GP; Ziegler JL; Graw RG; Levine AS; Deisseroth AB Blood; 1978 Jul; 52(1):85-95. PubMed ID: 350316 [TBL] [Abstract][Full Text] [Related]
29. Guanosine diphosphate-L-fucose plasma: N-acetylglucosaminide fucosyltransferase as in index of bone marrow hyperplasia after chemotherapy. Khilanani P; Chou TH; Kessel D Cancer Res; 1978 Jan; 38(1):181-4. PubMed ID: 271043 [TBL] [Abstract][Full Text] [Related]
30. High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer. Douer D; Champlin RE; Ho WG; Sarna GP; Wells JH; Graze PR; Cline MJ; Gale RP Am J Med; 1981 Dec; 71(6):973-6. PubMed ID: 7032290 [TBL] [Abstract][Full Text] [Related]
31. Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins. Appelbaum FR; Fefer A; Cheever MA; Buckner CD; Greenberg PD; Kaplan HG; Storb R; Thomas ED Blood; 1981 Sep; 58(3):509-13. PubMed ID: 7020711 [TBL] [Abstract][Full Text] [Related]
32. Thirty-one-year survival following chemotherapy and autologous bone marrow in malignant lymphoma. Haurani FI Am J Hematol; 1997 May; 55(1):35-8. PubMed ID: 9136915 [TBL] [Abstract][Full Text] [Related]
33. Role of massive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's malignant lymphoma. Philip T; Biron P; Maraninchi D; Gastaut JA; Hervé P; Flesh Y; Goldstone AH; Souhami RL Lancet; 1984 Feb; 1(8373):391. PubMed ID: 6141445 [No Abstract] [Full Text] [Related]
34. High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma. Armitage JO; Jagannath S; Spitzer G; Bierman P; Kessinger A; Kumar P; Cabanillas F; Zander A; Vellekoop L; Dicke KA Eur J Cancer Clin Oncol; 1986 Jul; 22(7):871-7. PubMed ID: 3533557 [TBL] [Abstract][Full Text] [Related]
35. Autologous bone marrow rescue in the treatment of advanced tumors of childhood. Ekert H; Ellis WM; Waters KD; Tauro GP Cancer; 1982 Feb; 49(3):603-9. PubMed ID: 7037150 [TBL] [Abstract][Full Text] [Related]
36. Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue. Köppler H; Pflüger KH; Havemann K Ann Hematol; 1991 Nov; 63(5):253-8. PubMed ID: 1958749 [TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy for advanced on-Hodgkin's lymphoma. Shetty PA; Nadkarni KS; Balavat RS; Sampat MB; Jussawalla DJ Indian J Med Res; 1980 Nov; 72():721-4. PubMed ID: 7203575 [No Abstract] [Full Text] [Related]
39. High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases: kinetics of recovery of haemopoiesis. A preliminary study of 12 cases. Gorin NC; Najman A; Salmon C; Muller JY; Petit JC; David R; Stachowiak J; Marie FH; Parlier Y; Duhamel G Eur J Cancer (1965); 1979 Sep; 15(9):1113-9. PubMed ID: 393517 [No Abstract] [Full Text] [Related]
40. McFarland W, Granville NB, Dameshek W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood. 1959;14(5):503-521. Blood; 2016 Apr; 127(15):1839. PubMed ID: 27081092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]